Immorna Biotherapeutics
↗Morrisville, USA
Immorna Biotherapeutics is a clinical-stage biotechnology company specializing in the development of next-generation RNA-based therapeutics and vaccines. Founded in 2019, the company utilizes multiple proprietary RNA platforms, including conventional mRNA, self-replicating RNA (srRNA), and circular RNA, to address unmet medical needs in oncology, infectious diseases, and rare genetic disorders.
The company is distinguished by its 'Ready-to-Use' (RTU) Lipid Nanoparticle (LNP) delivery technology, which enables long-term thermal stability at 2-8°C, a significant advantage over traditional mRNA vaccines requiring ultra-cold storage. Immorna operates globally with major R&D and manufacturing hubs in Morrisville, North Carolina, and Hangzhou, China.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:mRNA Therapeutics & Vaccines
SIZE & FINANCIALS
Employees:51-200
Revenue:$0M-$10M
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$115M
Investors:Bill & Melinda Gates Foundation, China Growth Capital, Hillhouse Capital, ZSVC, Co-win Ventures, Guangzhou Yuexiu Industrial Investment
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 1/2
Modalities:mRNA, Self-replicating RNA, Circular RNA, LNP Delivery, In vivo CAR therapy
Active Trials:4
Trial Phases:Phase 1: 2 | Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Hangzhou Immorna Biotech Inc.
Key Partnerships:Junshi Biosciences (Joint Venture for mRNA therapeutics), I-Mab Biopharma (Antibody-encoding mRNA collaboration), Shenzhen Kangtai Biological Products (Infectious disease vaccines)
COMPETITION
Position:Emerging
Competitors:Moderna, BioNTech, CureVac, Arcturus Therapeutics, Innorna, Abogen Biosciences
LEADERSHIP
Key Executives:
Zihao Wang, Ph.D. - Co-founder & CEO
NgocDiep Le, M.D., Ph.D. - Global Chief Medical Officer
Scientific Founders:Zihao Wang
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immorna Biotherapeutics. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.